| Shannon Victoria Lenox, RN | |
|
436 Main St, Trenton, NJ 08620-2318 | |
| (609) 306-5196 | |
| Not Available |
| Full Name | Shannon Victoria Lenox |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 436 Main St, Trenton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225623358 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR22441100 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Victoria Lenox, RN 436 Main St, Trenton, NJ 08620-2318 Ph: (609) 306-5196 | Shannon Victoria Lenox, RN 436 Main St, Trenton, NJ 08620-2318 Ph: (609) 306-5196 |
News Archive
As an example of how the normally sclerotic Congress can act extremely quickly when properly motivated, both chambers passed bills this week to ameliorate the Veterans Affairs health services scandal.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that it has completed the enrolment of the second Phase III trial evaluating microplasmin for the non-surgical treatment of eye disease.
MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.
A team of scientists from the University of Oxford, U.K. have taken lessons from Adam Smith and Charles Darwin to devise a new strategy that could one day slow, possibly even prevent, the spread of drug-resistant bacteria. In a new research report published in the March 2011 issue of GENETICS, the scientists show that bacterial gene mutations that lead to drug resistance come at a biological cost not borne by nonresistant strains.
GTC Biotherapeutics, Inc.'s total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.
› Verified 9 days ago
Justine M Sponziello, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Hamilton Ave, Trenton, NJ 08629 Phone: 609-599-5000 | |
Theresa Baker, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Hamilton Ave, Trenton, NJ 08629 Phone: 609-599-5000 | |
Bernice Jones, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 150 Estates Blvd Apt G105, Trenton, NJ 08610 Phone: 917-306-6417 | |
Mr. Kenneth R Wolski, RN, MPA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 219 Woodside Ave, Trenton, NJ 08618 Phone: 609-394-2137 | |
Phyllis Yuen Mak, RNFAG Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 908-917-1111 | |
Milo Haws, TMBT Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 225 E State St Ste 12, Trenton, NJ 08608 Phone: 609-695-8100 | |
Claire Corrielus, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 132 Perry St, Trenton, NJ 08618 Phone: 609-394-8988 Fax: 609-599-1561 |